Acurx Pharmaceuticals (ACXP) said Friday in a regulatory filing some selling shareholders may sell up to about 2.6 million shares.
The number of shares comprises up to about 2.46 million shares issuable upon exercise of Series E warrants acquired by some of the shareholders under a purchase agreement with an exercise price of $0.90 per share and up to 147,783 shares issuable upon exercise of placement agent warrants, the company said.
The selling shareholders will get all of the proceeds from any sales of the shares, Acurx said.
Acurx shares rose 3.3% in after-hours trading.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。